Literature DB >> 35203009

Chronotropic index during 6-minute walk and acute respiratory events in COPDGene.

David M Macdonald1, Elise F Palzer2, Asghar Abbasi3, Arianne K Baldomero4, Surya P Bhatt5, Richard Casaburi3, John E Connett2, Mark T Dransfield5, Nathaniel T Gaeckle6, Takudzwa Mkorombindo5, Harry B Rossiter3, William W Stringer3, Nicholas B Tiller3, Chris H Wendt4, Dongxing Zhao7, Ken M Kunisaki4.   

Abstract

BACKGROUND: Lower heart rate (HR) increases during exercise and slower HR recovery (HRR) after exercise are markers of worse autonomic function that may be associated with risk of acute respiratory events (ARE).
METHODS: Data from 6-min walk testing (6MWT) in COPDGene were used to calculate the chronotropic index (CI) [(HR immediately post 6MWT - resting HR)/((220 - age) - resting HR)] and HRR at 1 min after 6MWT completion. We used zero-inflated negative binomial regression to test associations of CI and HRR with rates of any ARE (requiring steroids and/or antibiotics) and severe ARE (requiring emergency department visit or hospitalization), among all participants and in spirometry subgroups (normal, chronic obstructive pulmonary disease [COPD], and preserved ratio with impaired spirometry).
RESULTS: Among 4,484 participants, mean follow-up time was 4.1 years, and 1,966 had COPD. Among all participants, CI-6MWT was not associated with rate of any ARE [adjusted incidence rate ratio (aIRR) 0.98 (0.95-1.01)], but higher CI-6MWT was associated with lower rate of severe ARE [0.95 (0.92-0.99)]. Higher HRR was associated with a lower rate of both any ARE [0.97 (0.95-0.99)] and severe ARE [0.95 (0.92-0.98)]. Results were similar in the COPD spirometry subgroup.
CONCLUSION: Heart rate measures derived from 6MWT tests may have utility in predicting risk of acute respiratory events and COPD exacerbations. Published by Elsevier Ltd.

Entities:  

Keywords:  Cardiac chronotropy; Chronic obstructive; Cohort study; Disease exacerbation; Pulmonary disease

Mesh:

Year:  2022        PMID: 35203009      PMCID: PMC8932051          DOI: 10.1016/j.rmed.2022.106775

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  35 in total

1.  The effect of lung volume reduction surgery on chronotropic incompetence.

Authors:  Hilary F Armstrong; Jose Gonzalez-Costello; Ulrich P Jorde; Mark E Ginsburg; Aimee M Layton; Byron M Thomashow; Matthew N Bartels
Journal:  Respir Med       Date:  2012-07-06       Impact factor: 3.415

Review 2.  The autonomic nervous system and hypertension.

Authors:  Giuseppe Mancia; Guido Grassi
Journal:  Circ Res       Date:  2014-05-23       Impact factor: 17.367

Review 3.  Sympathetic activation in heart failure and its treatment with beta-blockade.

Authors:  G S Pepper; R W Lee
Journal:  Arch Intern Med       Date:  1999-02-08

Review 4.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.

Authors:  Dave Singh; Alvar Agusti; Antonio Anzueto; Peter J Barnes; Jean Bourbeau; Bartolome R Celli; Gerard J Criner; Peter Frith; David M G Halpin; Meilan Han; M Victorina López Varela; Fernando Martinez; Maria Montes de Oca; Alberto Papi; Ian D Pavord; Nicolas Roche; Donald D Sin; Robert Stockley; Jørgen Vestbo; Jadwiga A Wedzicha; Claus Vogelmeier
Journal:  Eur Respir J       Date:  2019-05-18       Impact factor: 16.671

5.  Post-exercise heart rate recovery and mortality in chronic obstructive pulmonary disease.

Authors:  Miriam Lacasse; François Maltais; Paul Poirier; Yves Lacasse; Karine Marquis; Jean Jobin; Pierre LeBlanc
Journal:  Respir Med       Date:  2005-01-20       Impact factor: 3.415

6.  Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Emily B Schroeder; Lloyd E Chambless; Duanping Liao; Ronald J Prineas; Gregory W Evans; Wayne D Rosamond; Gerardo Heiss
Journal:  Diabetes Care       Date:  2005-03       Impact factor: 19.112

7.  Relation of heart rate parameters during exercise test to sudden death and all-cause mortality in asymptomatic men.

Authors:  A Selcuk Adabag; Gregory A Grandits; Ronald J Prineas; Richard S Crow; Hanna E Bloomfield; James D Neaton
Journal:  Am J Cardiol       Date:  2008-03-19       Impact factor: 2.778

8.  Chronotropic incompetence can limit exercise tolerance in COPD patients with lung hyperinflation.

Authors:  Sébastien Hulo; Jocelyn Inamo; Aurélie Dehon; Olivier Le Rouzic; Jean-Louis Edme; Remi Neviere
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-10-17

9.  Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort.

Authors:  Robert Busch; MeiLan K Han; Russell P Bowler; Mark T Dransfield; J Michael Wells; Elizabeth A Regan; Craig P Hersh
Journal:  BMC Pulm Med       Date:  2016-02-10       Impact factor: 3.317

10.  A Risk Prediction Model for Mortality Among Smokers in the COPDGene® Study.

Authors:  Matthew Strand; Erin Austin; Matthew Moll; Katherine A Pratte; Elizabeth A Regan; Lystra P Hayden; Surya P Bhatt; Aladin M Boriek; Richard Casaburi; Edwin K Silverman; Spyridon Fortis; Ingo Ruczinski; Harald Koegler; Harry B Rossiter; Mariaelena Occhipinti; Nicola A Hanania; Hirut T Gebrekristos; David A Lynch; Ken M Kunisaki; Kendra A Young; Jessica C Sieren; Margaret Ragland; John E Hokanson; Sharon M Lutz; Barry J Make; Gregory L Kinney; Michael H Cho; Massimo Pistolesi; Dawn L DeMeo; Frank C Sciurba; Alejandro P Comellas; Alejandro A Diaz; Igor Barjaktarevic; Russell P Bowler; Richard E Kanner; Stephen P Peters; Victor E Ortega; Mark T Dransfield; James D Crapo
Journal:  Chronic Obstr Pulm Dis       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.